What is clonal anergy and how can it affect vaccine effectiveness?

• A. T cells become unresponsive due to lack of co-stimulation; can reduce vaccine-induced T cell responses.
• B. B cells become hyperactive; increases antibody production.
• C. T cells become hyperresponsive due to co-stimulation; enhances vaccine response.
• D. B cells undergo class switching independently; no effect on vaccine.

Answer: (A)

Clonal anergy is a state where a T cell recognizes an antigen but does not receive the second activation signal it needs. Without this co-stimulation, the T cell becomes functionally inactivated: it won’t proliferate, won’t secrete the key cytokines, and won’t differentiate into effector helpers or killers. In vaccines, effective T cell responses depend on two signals: TCR recognition of the presented antigen and a co-stimulatory cue from antigen-presenting cells. Adjuvants and innate immune activation help provide that second signal, tipping T cells into an active, protective response rather than an anergic, unresponsive one. If co-stimulation is missing or weak, T cells enter clonal anergy, dampening the overall immune response a vaccine can provoke.

This matters for vaccine effectiveness because helper T cells are essential for helping B cells produce high-affinity antibodies and undergo class switching, and cytotoxic T cells are needed to target infected cells. If T cells are anergic, these downstream pathways are blunted, leading to weaker antibody responses, less durable immunity, and reduced protection.

Other descriptions that imply B cells becoming hyperactive or T cells becoming hyperresponsive don’t align with clonal anergy. Anergy specifically describes a nonresponsive T cell state due to insufficient co-stimulation, not increased activity.